Epirium Bio Inc. (Epirium), a clinical-stage biopharmaceutical company advancing medicines for neuromuscular and fibrotic diseases, today announced positive results from its Phase 1 trial evaluating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback